B3GAT1 and metastatic melanoma: Furthermore, metastatic melanoma patients with a higher ratio of CD57+CD56dim to CD57+CD56bright NK cells in the metastatic lymph nodes showed better survival compared to patients with a lower ratio with the same disease stage [93], suggesting that NK cell cytotoxicity in the metastatic lymph node may be important for disease control.